Introduction
The vessel wall, comprising endothelial cells, vascular smooth muscle cells (VSMCs) and the extracellular matrix (ECM), is very sensitive to diverse stimuli, including mechanical forces and neurohumoral factors. Multiple studies confirm that VSMCs play a key role in arterial wall homeostasis [1, 2] . Complex VSMCs biology important in the pathogenesis of atherosclerosis, however, remains poorly understood [3e5] . The VSMCs response in different pathological conditions is less well-studied, especially in vivo and in human tissue. The VSMCs response to ischemic events in humans is missing and might shed light on our understanding of the atherosclerotic process progression. This knowledge could be applied to the management of ischemic heart disease and lead to substantial changes in the prevention and treatment of patients with myocardial infarction (MI).
In the MI model, VSMCs are engaged and essential in the regulation of the ECM and inflammatory responses. Previous studies in rat models [6] have demonstrated the application of microarray gene expression technology in detecting local underlying changes in myocardial tissues. In addition, these studies have demonstrated that microarray analysis is an established method that can be adopted for the identification of novel molecular mechanisms in diseases [6, 7] . In this study, we aim to identify the significant transcriptome of VSMCs in the laser micro-dissected aortic walls of MI patients compared with those of non-MI patients. We use aortic punch tissue samples obtained during coronary artery bypass graft (CABG) surgery.
Materials and methods

Study population
All samples were obtained from patients with coronary artery disease, undergoing CABG at the National University Hospital of Singapore from 2009 to 2013. Patients underwent CABG either after a recent myocardial infarction (MI group) or as stable angina patients (non-MI group). Patients were included in the MI group if they had sustained a non-ST elevation MI less than 5 days before surgery, with a troponin I raise of at least 10 times the upper limit of normal. Patients were recruited as non-MI patients if they did not have an acute cardiovascular event before surgery. Patients who had hemodynamic compromise, desaturation, and other cardiovascular complications were excluded from this study. All patients were on therapy, including statins, b-blockers and antiplatelet medication. The study was approved by the National Healthcare Group Domain Specific Review Board, and written informed consent was obtained from all patients. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki. Details of the aortic tissue collection and processing of the tissue are provided in our Data in Brief article [8] . Staining was performed on aortic sections to enhance the visibility of VSMCs with typical elongated and spindle-shaped morphology (Fig. 1) .
In total, 17 MI patients and 19 non-MI patients were recruited for LCM and microarray profiling. The proteomic study included 25 MI and 25 non-MI patients. Four MI and six non-MI patients overlapped between the microarray and proteomic studies. RTqPCR was done on an independent cohort of patients, including an additional 20 MI and 20 non-MI patients. A schematic of the design and workflow is presented in Fig. 2 
Microarray data analysis
Samples analyzed on the Affymetrix platform were preprocessed using the Raw CEL; data sets of all samples were normalized by the robust multi-array average (RMA) algorithm using the R package affy [9] . The probe set intensity was expressed as log (2)-transformed values. To adjust for potential batch effects, we applied an R implementation of the non-parametric batch effect correction method, ComBat [10] , available from the Bioconductor (www.bioconductor.org) package. After normalizing a batch of arrays to make further comparisons meaningful, we performed principal component analysis (PCA). In all analyses, p-value <.05 was considered statistically significant. The statistical analysis was carried out with the R package (https://cran.r-project.org/) and piano package under the R software environment [11] . Proportional and cumulative variance expressed by the top principal component was shown by following the idea of Federica Censi et al. [12] .
Normalized microarray data were used for class prediction based on a modified nearest-centroid classification or Prediction analysis of microarray (PAM) analysis [13] using 10-fold crossvalidation on the 37 samples. Herein, we used PAM for dimensionality reduction to obtain the most informative and representative features from the entire set of microarray probe sets that discriminated between MI and non-MI patients. PAM was implemented via the "pamr" R package [13] .
To identify groups of functionally related genes, gene ontology (GO) analysis was performed using the DAVID Bioinformatics database (https://david.ncifcrf.gov/) [14] . The Ingenuity Pathway Analysis (IPA) software (Ingenuity ® Systems, www.qiagen.com/ ingenuity) was used to identify statistically relevant canonical pathways associated with the lists of differentially expressed genes. The Affymetrix CEL files are available from the NCBI's Gene Expression Omnibus under accession number GSE83500 (http:// www.ncbi.nlm.nih.gov/geo/query/acc.cgi? token¼ghqlwywubbohvmj&acc¼GSE83500).
Protein processing, electrostatic repulsion-hydrophilic interaction chromatography (ERLIC) and LC-MS/MS analysis using Q-Exactive mass spectrometer
Individual aortic samples from each sample group MI (n ¼ 25) and non-MI (n ¼ 25) were homogenized using the Bullet Blender™ (Next Advance, Averill Park, NY) with 0.9e2.0 mm stainless steel bead blend as per manufacturers' adapted protocol. 20 mL of extracted aortic proteins lysate from patients under the same group was pooled. Digestion was carried out with sequencing grade modified trypsin (Promega Corporation, Madison, WI) at a 1:100 (w/w, trypsin to protein) ratio. The tryptic peptides were dried in a vacuum concentrator (Thermo Electron, Waltham, MA) and labeled with 8-plex isobaric tags (Applied Biosystems, Foster City, CA) as follows: MI and non-MI (NMI). iTRAQ-labeled peptides (~1600 mg) were reconstituted in 200 mL of Mobile phase A (85% ACN, 0.1% HAc, 5 mM CH 3 COONH 4 ) and fractionated using a PolyWAX LP anionexchange column (4.6 Â 200 mm, 5 mm, 300 Å, PolyLC, Columbia, MD) on a Shimadzu Prominence UFLC system (Kyoto, Japan). UV spectra of peptides were collected at 280 nm. Three technical replicates of iTRAQ-labeled peptides were separated and analyzed in an LC-MS/MS system comprised of a Dionex Ultimate 3000 RSLC nano-HPLC system, coupled to an online Q-Exactive hybrid quadrupole-Orbitrap mass spectrometer (Thermo Scientific, Hudson, NH, USA). Spectral data analysis was performed using Thermo Scientific™ Proteome Discoverer™ (PD) 1.4 software, connected to SEQUEST ® HT search engine, a high-performance implementation of the SEQUEST™ algorithm. The spectra were searched against the Uniprot Human database (Released on 20130405, 121862 sequences; 43940360 residues) for protein identification. Automatic target-decoy search strategy was used in combination with Percolator to score peptide spectral matches for estimation of false discovery rates (FDR). Only peptides identified with strict spectral FDR less than 1% (q-value 0.01) were considered. The reported precursor ion quantitation ratios of MI 115 /NMI 116 were derived by the selection of the respective quantification values as numerator and denominator in the ratio reporting tab, within the default iTRAQ 8-plex quantitation method editor in PD1.4. As anticipated with the pro-atherogenicity of low density lipoproteins in coronary artery disease pathology [15] , herein apolipoprotein(a) (LPA) was reported with a 1.206-fold change (Table 8 in Ref. [8] ) in MI aortic tissues relative to NMI aortic tissues. Hence, taking this into consideration, a fold change cut-off was set at 1.2 and 0.83 to indicate up-regulated and down-regulated proteins, respectively. Expression ratios of target proteins of interest were extracted and p-values determined by unpaired Student's t-test. A p-value <.05 was indicates statistical significance.
RT-qPCR on an independent cohort of MI and non-MI patients
Genes were chosen for qPCR based on the statistical result of the primary microarray experiments, PAM, and GO analysis, with a focus on VSMCs-relevant mRNA and pathway analysis. Total RNA was isolated with miRCURY™ RNA Isolation Kit (Exiqon, Denmark). The solubilized RNA was further treated with endonuclease DNase I (Life Technologies; Thermo Fisher Scientific Inc, USA). cDNA was prepared with iScript™ Advanced cDNA Synthesis Kit (Bio-Rad Laboratories; USA).
Gene expression was analyzed by RT-qPCR with SsoFast™ EvaGreen ® Supermix with Low ROX Supermix (Bio-Rad Laboratories;
USA) using QuantStudio™ 12 K Flex system (Life Technologies; Thermo Fisher Scientific Inc, USA). A list of primers is shown in
Ref. [8] . The gene expression levels were normalized to the median threshold of the b-actin gene within the samples using the 2 ÀDDCT method.
Results
Clinical analysis
The characteristics of MI (n ¼ 17) and non-MI (n ¼ 19) patients undergoing transcriptomics are presented in Table 1A in Ref. [8] . The groups did not differ for any characteristics except for troponin I test results, reflecting recent NSTEMI in the MI group. Similarly, the demographic and clinical characteristics of MI (n ¼ 25) and non-MI (n ¼ 25) patients undergoing proteomic studies did not differ (Table 1B in Ref. [8] ). The baseline demographic and clinical characteristics of the 36 patients undergoing the transcriptomics study were compared with those of the 50 patients from the proteomics study. The mean age ±SD was 59.61 ± 18.47 years and 61.28 ± 10.40 years for the transcriptomic (n ¼ 36) and proteomic (n ¼ 50) study groups, respectively. Furthermore, there were no significant differences in the demographic and clinical characteristics between the transcriptomic and proteomic study groups ( Table 2 in Ref. [8] ).
In addition, we compared the characteristics of transcriptomic MI (n ¼ 17) and non-MI (n ¼ 19) patients with those of the independent cohorts, comprising additional MI (n ¼ 20) and non-MI (n ¼ 20) patients undergoing RT-qPCR (Tables 3 and 4 in Ref. [8] ), and found no significant differences.
Gene expression data analysis and class prediction by PAM
The samples were preprocessed through several steps, including quality assessment and outlier identification, normalization, batch effect correction and evaluation ( Fig. 1 in Ref. [8] ). To assess differentially expressed genes between MI and non-MI, we conducted gene-expression profiling using the Affymetrix U219 microarray platform. Overall, 4357 transcripts were differentially expressed in MI with p-value less than 0.05. Based on this set of gene, we performed PCA and observed that the two different groups were separated ( Fig. 1 in Ref. [8] ).
To determine subgroup of genes distinguishing MI from non-MI subjects, we performed supervised PAM [13] . The prediction error was estimated via 10-fold cross validation. A set of 370 differentially expressed genes (DEGs) (51 down-and 319 up-regulated; Table 5 in Ref. [8] ) discriminating between the two subtypes was identified with an accuracy of 84%.
GO analysis of the 370 DEGs was performed using DAVID Bioinformatics tools [14] (http://david.abcc.ncifcrf.gov/). The GO results for the down-regulated transcripts were not enriched for any GO terms. GO analysis of the 319 up-regulated DEGs revealed biological processes related to muscle regulation. These biological processes included smooth muscle contraction, muscle cell differentiation, skeletal muscle fiber development, striated muscle tissue development and actin cytoskeleton organization (Table 6 in Ref. [8] ).
To improve the biological interpretability, we integrated functional annotations retrieved from the GO into further analysis. Given that transcriptomics was performed on LCM-isolated VSMCs, enriched muscle-related genes identified by GO analysis were selected for cluster analysis. Genes differently expressed by less than 1.25-fold (MI/non-MI) and with a p-value !.05 were removed. In total, 21 genes (Table 1) were used for clustering by two methods, hierarchical and K-mean clustering. Hierarchical clustering with multiscale bootstrap resampling was done with Pvclust, an R statistical software package [16] . The pvclust is an R package to assess the uncertainty in hierarchical cluster analysis. For each cluster in hierarchical clustering, quantities called p-values are calculated via multiscale bootstrap resampling. The parameters (https://cran.r-project.org/web/packages/pvclust/pvclust.pdf) used here were 10,000 bootstrap replications, cluster method: Ward algorithm and distance method: Euclidean. For the heat maps plot, we used log 2 scale.
The k-mean clustering was also performed by R (https://stat. ethz.ch/R-manual/R-devel/library/stats/html/kmeans.html). Both clustering methods showed that the selection of features gave a higher accuracy than PAM alone. A minimal set of 21 genes discriminated between MI and non-MI VSMCs samples with an accuracy of 92% (Table 7 in Ref. [8] ). A clustered result is shown in Fig. 2. 
Result of RT-qPCR on an independent cohort of MI and non-MI patients
RT-qPCR analysis was performed using whole aorta tissue samples obtained from independent cohorts of MI (n ¼ 20) and non-MI (n ¼ 20) patients. We selected 8 out of the 21 genes in the VSMCs-associated classifier identified: SOD1, ATP1A2, GUCY1A3, and MYOCD (based on GO results in relevance to VSMCs), as well as ARF6, UBB, and KLHL1 (three top significantly up-regulated mRNAs). In addition, we also validated HIF-1A, a crucial gene in the top significant pathway.
The expression levels of VSMCs-related genes, SOD1, ATP1A2, and MYOCD, confirmed up-regulation in the MI group (1.37-fold (p ¼ .287), 6.68-fold (p ¼ .030), and 12.6-fold (p ¼ .009) changes, respectively). KLHL and ARF6, as the top significant up-regulated transcripts among those in the 21-gene VSMCs-associated classifier, were up-regulated in MI patients by RT-qPCR, as well (6.9-fold (p ¼ .125) and 8.2-fold (p ¼ 6.66 Â 10 À5 ) change, respectively).
Expression of the GUCY1A3 gene transcript did not differ between MI and non-MI groups (0.93-fold change; p ¼ .223). UBB expression value showed a 0.50-fold change in the MI group in the opposite direction to that of the original microarray data. The mRNA of HIF-1A revealed over-expression (1.33-fold change; p ¼ .046) in MI tissue samples, which was congruent with the original array analysis in the LCM-derived samples (Fig. 3) .
Hierarchical cluster analysis of the six RT-qPCR-based detected genes
We considered the six RT-qPCR-supported genes as a representative gene classifier characterizing differences between MI and non-MI aortic samples. Using these genes, we performed hierarchical clustering with multiscale bootstrap resampling by Pvclust, an R statistical software package [16] . The clustering result showed that the six genes distinguished MI from non-MI samples with 73% accuracy. This result is consistent with the correlation between the 21-gene classifier and the representative six-gene classifier (Kappa ¼ 0.451, p-value ¼ .0084) (Fig. 2 in Ref. [8] ).
Protein analysis
Using iTRAQ, 94 proteins were differentially expressed. In the MI group, 58 proteins were increased (cutoff ratio>1.2 (MI/non-MI)), and 36 proteins were decreased (cutoff ratio<0.83 (MI/non-MI)) compared with the non-MI group (Table 8 in Ref. [8] ). The most prominent changes were found in serpin family E member 2 (SERPINE2), also known as protease nexin-1 (PN-1), and elastin microfibril interface located protein 2 (EMILIN2). SERPINE2 expression was increased approximately 2.7-fold, and EMILIN2 expression was approximately 2.5-fold higher in the MI group. SOD1 expression was 1.21-fold higher in the MI group.
Transcriptomic pathways analysis
To identify transcriptomic pathways in which the 370 DEGs were involved and enriched, systemic evaluation was performed using IPA (www.ingenuity.com). Thirteen significantly enriched canonical pathways identified by IPA are shown in Table 9 in Ref. [8] . The top enriched pathways in IPA were associated with hypoxia signaling in the cardiovascular system (pvalue ¼ 9.48 Â 10 À4 ), (Fig. 4A) . The HIF-1A, UBE2, and CREB1 genes involved in hypoxia signaling pathways were up-regulated in our data.
Pathway analysis of different proteins
The 94-protein subset was also input into the IPA to identify significant canonical pathways. Thirteen significant pathways are Table 9 in Ref. [8] . Proteomic analysis of the canonical pathways indicated that the most enriched pathways were associated with superoxide radical degradation (p-value ¼ 5.42 Â 10 À4 ).
Two antioxidant enzymes, superoxide dismutase 1 (SOD1) and catalase (CAT), were incorporated into the superoxide radical degradation pathway (Fig. 4B ).
A common pathway and common molecule
To assess whether the top candidate molecules from the transcriptome and proteome were enriched in any specific pathway, we combined the 21-gene VSMCs-associated classifier and 94-protein subset and mapped them to pathways using IPA. Enriched pathways were derived from the analysis shown in Table 10 in Ref. [8] . An integrated transcriptome-proteome correlation indicated that the superoxide radical degradation pathway remained the most implicated pathway (p-value ¼ 7.90 Â 10
À4
). The common molecule, superoxide dismutase (SOD1), was highlighted at the intersection of the top candidate molecules from the transcriptome (21-gene subset) and proteome (94-protein subset) and qPCR results.
Discussion
Hypoxia due to ischemia generates powerful responses, incorporating inflammation, changes in enzyme activity, oxygen utilization and ROS generation, with effects on tissue plasticity and cellular proliferation [17] . The nature of the local response to hypoxia is well established; however, the remote biological feedback is less well recognized or understood. To date, cardiac hypoxia or ischemic injury, as a mechanism connecting the systemic vasculature to the heart, has been investigated in the context of the "ischemic preconditioning" phenomenon. This term is routinely used by the cardiovascular community, but remains underinvestigated and poorly understood [18] . In our project, we focused on human VSMCs as a target to elucidate the remote effect of myocardial infarction (end-organ hypoxia) on the vascular system. A significant innovation in this study was the use of human ascending aortic wall VSMCs to evaluate the systemic effect of myocardial infarction on the living human body. Access to fresh ascending aorta whole-thickness punches made VSMCs attainable by the LCM method. The combination of several high-throughput technologies and bioinformatics methods provided insights into the molecular responses associated with MI in remote VSMCs. Alterations in VSMCs transcription evaluated by pathway analysis reveal potential relation of underline changes to the progression of the atherosclerotic process [19, 20] .
Gene expression profiling of VSMCs from the aortic wall using a microarray revealed 370 DEGs, discriminating between MI and non-MI VSMCs with an accuracy of 84%. By performing gene functional annotation on these DEGs, we found that these transcripts were enriched in muscle-related processes.
To focus our LCM-dissected VSMCs study, we were able to extract a subset of differentially regulated muscle-related genes distinguishing MI from non-MI cases. A total of 21 genes represented muscle-related biological processes. Selecting the 21 upregulated muscle-related genes improved the separation between the two groups, with an increased accuracy of up to 92%. The SOD1, ATP1A2, GUCY1A3, MYOCD as VSMCs-related genes, and KLHL1, ARF6 genes, as the top significant up-regulated transcripts among the 21-gene classifier, were chosen for further analysis. The microarray pattern were re-evaluated by RT-qPCR on the whole aortic tissue sample. The RT-qPCR results revealed congruent direction and magnitude of changes in five genes, including three VSMCs genes: ATP1A2, MYOCD, SOD1.
The up-regulated VSMCs-related genes have been reported to be associated with MI in several mouse model papers. The Na
ATPase a2-isoform (ATP1A2) encodes an ATPase that regulates the Na þ /K þ -channel transport in response to metabolic stress, causing an increase in vessel contraction in the mouse thoracic aorta [21] . Myocardin (MYOCD) is a myogenic co-activator expressed in VSMCs. A study in mouse tissues reported that MYOCD interacts with the serum response factor (SRF) and activates genes in the CArG boxes, leading to the activation of smooth muscle cells (SMCs) differentiation mechanisms [22] . Superoxide dismutase 1 (SOD1) is known for its role in the governance of H 2 O 2 in the vasculature and regulates cellular oxidative signaling mechanisms in mouse VSMCs [23] . Our finding of an up-regulation of VSMCs-related genes, ATP1A2, MYOCD and SOD1, in aortic VSMCs in patients with recent acute MI, is reported for the first time in humans. Further functional investigations of the underlying mechanisms of the aortic response are necessary.
ADP-ribosylation factor 6 (ARF6) has been known for its role in peripheral actin remodeling and VSMCs proliferation via the MAPK pathway in response to increased ROS generation [24] . A noncardiovascular SMCs-related gene, Kelch Like Family Member 1 (KLHL1), was found up-regulated in our microarray analysis. KLHL1, a brain-specific transcript, has not been previously reported as upregulated in cardiovascular tissue in relation to MI. Further investigation is necessary to assess the role of KLHL1 in VSMCs of MI patients.
The most prominent changes in proteomic analysis were found in two smooth muscle-related proteins, SERPINE2 and EMILIN2. Serpin family E member 2 (SERPINE2) contributes to homeostasis in the cardiovascular system by participating in tissue remodeling. This protein is highly expressed in the heart and acts directly or indirectly on cells or tissues modulating mechanisms such as cellular adhesion and cellular proliferation [25] . As a constituent of the vessel wall, EMILIN2 may have a role in thrombosis at the site of a plaque -the key precipitating event in the transition from subclinical atherosclerotic disease to acute MI [26] .
The top enriched pathways identified in VSMCs by IPA were associated with hypoxia signaling in the cardiovascular system (pvalue ¼ 9.48 Â 10 À4 ) (Fig. 4) . The HIF-1A, UBE2, and CREB1 genes involved in hypoxia signaling pathways were up-regulated in our data. This data allow us to assume that one of the potential mechanisms driving changes in VSMCs could be the hypoxia signaling pathway activation. The design of the study excluded all patients with systemic hypoxia and allowed us speculating that this change is related to myocardial ischemia and hypoxia. The key mRNA of hypoxia signaling pathway, HIF-1A, underwent reevaluation on independent cohorts of patients by RT-qPCR and revealed significant up-regulation in the MI group consistent with the original microarray analysis. The most enriched pathway on protein-based analysis turned out to be the degradation pathway for superoxide radicals. Two antioxidant enzymes, SOD1 and CAT, were highlighted by this pathway. The O2À is the most important ROS in vascular cells. It is dismutased to H 2 O 2 by SOD1. H 2 O 2 can be converted to H 2 O by catalase. Both enzymes decrease the level of H 2 O 2 , which is deleterious to the cell [27] .
Combined pathway analysis based on the 21-gene VSMCs classifier and the 94-protein subset highlighted that the superoxide radical degradation pathway remained the cardinal pathway. Two forms of analyses (proteomic and transcriptomic) strongly suggested that VSMCs in the aortic wall of patients with MI have a distinct superoxide radical degradation pathway activation. However, this result has to take into account that transcriptomic data came from pure VSMCs but proteins were identified on whole aorta tissue sample. Although it is a very interesting result, it can only support our transcriptomic data rather than validate it.
In our study, SOD1 revealed up-regulation by all three applied methods: transcriptomic data set from VSMCs LCM, proteomic data derived from aortic tissue, RT-qPCR from aortic tissue. This molecule was highlighted by two pathways: hypoxia response pathways, enlightened by transcriptomic data, and superoxide radical degradation pathway, revealed by proteomic analysis. SOD1 is an antioxidant that protects cells against oxidative stress -a key contributor to cardiovascular disease [27] . In the vessel, alterations in the levels of O2À modulate vascular tone, gene expression, cellular growth, inflammation, and signaling [28] . SOD1 acts to reduce the effects of oxidative stress by catalyzing the dismutation of the superoxide anion into hydrogen peroxide and oxygen. SOD1, therefore, serves as front-line defense against ROS in the cells [28] . The literature shows that ROS production can be related to hypoxia, affecting cells at the mitochondrion electron transport chain level [29] . Stimulated by ROS production, hypoxia leads to increased expression of a main vascular enzymatic antioxidant -SOD1. The literature has shown that ROS production evokes vascular wall remodeling by enhancing expression of myocardin (MYOCD) [30] . In addition, ROS can induce expression of guanylate cyclase-1-soluble A-3 (GUCY1A3) [31] . This gene was previously identified as a risk gene for myocardial infarction [32] .
Conclusions
For the first time, transcripts of LCM-extracted VSMCs of the aortic wall from MI and non-MI patients were analyzed. The gene expression profiling analysis identified a novel 21-gene VSMCsassociated classifier distinguishing VSMCs responses to MI at a transcriptomic level. Analysis using IPA revealed hypoxia signaling in cardiovascular system as a top activated pathway in VSMCs of MI patients. The implementation of systems biology strategies demonstrated complementary transcriptomic and proteomic changes, which identified activation of SOD1 in the aortic wall of MI patients. Further elucidation of the aortic wall response to myocardial ischemia may help understand the clinical implication of the described transcript alteration and its involvement in the progression of atherosclerosis.
Study limitations
The proteomic study was performed on aortic tissue rather than LCM VSMCs. Proteomic result cannot be claimed as VSMCs proteomic analysis. RT-qPCR was performed on heterogenic cells from aortic biopsy, unlike the original array data, which were performed on VSMCs extracted with the LCM method. However, we find this result important since RT-qPCR evaluates only VSMCs-related genes.
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